The Fiscal Year 2005 (FY05) Appropriation Bill was signed by President Bush on August 5, 2004. This program announcement is being released prior to the receipt of funds appropriated in the bill for this research program; funding of proposals received in response to this program announcement is contingent on the receipt of funds at the United States Army Medical Research and Materiel Command (USAMRMC).
The United States Army Medical Research and Materiel Command (USAMRMC), Office of the Congressionally Directed Medical Research Programs (CDMRP) invites applications for funding for the FY05 Neurofibromatosis Research Program (NFRP) Concept Awards.
The overall goal of the FY05 NFRP is to develop effective therapies for NF1, NF2, and Schwannomatosis. Within this context, support for the training of NF researchers, the encouragement of established scientists in the field, and the attraction of new scientific expertise from other fields are essential to the NF community. Proposals to the NFRP are sought across all areas of laboratory, clinical, behavioral, and epidemiological research including all disciplines within the basic, clinical, psychosocial, behavioral, sociocultural, and environmental sciences; nursing; occupational health; alternative therapies; public health and policy; and economics. Additionally, proposals that address the needs of minority, low-income, rural, and other underrepresented and/or medically underserved populations may be submitted from any eligible institutional source. Proposals are encouraged from investigators working at Historically Black Colleges and Universities/Minority Institutions (HBCU/MI). The intent of the Concept Award is to fund the exploration of an initial concept or theory that could give rise to a testable hypothesis. These awards provide investigators with the opportunity to pursue serendipitous observations; it is anticipated that research completed through a Concept Award may provide sufficient preliminary data to enable the investigator to prepare a hypothesis-based proposal for future research. Presentation of preliminary data is not consistent with the intent of this award mechanism. Proposals must describe how the new concept or theory will enhance existing knowledge of NF1, NF2, and/or Schwannomatosis. Concepts from complementary areas of science such as chemistry, biophysics, mathematics, engineering, etc., are encouraged as are research proposals involving consumer-scientist collaborations. Because these awards are designed for preliminary investigations, projects involving human subjects or human anatomical substances will not be supported through this mechanism unless they are exempt under 32 CFR 219.101(b)(4). Studies that do not qualify for exempt status will be administratively withdrawn and will not be funded.
The nature of the NFRP does not allow for renewal of grants or supplementation of existing grants. Depending on the quality and the number of proposals received, the CDMRP expects to allot approximately $1M to fund approximately 10 Concept Awards.
Funding for Concept Awards can be requested for a maximum of $100,000 inclusive of both direct and indirect costs over a 1-year performance period. Projects requiring lower levels of funding also may be submitted. These funds can cover salary, expenses including research supplies, and travel to scientific/technical meetings. The amount allotted for this travel is $1,800 per year.
Electronic submission is required. Proposals will be accepted only as PDF files submitted through the CDMRP eReceipt system. No paper copy submissions will be accepted. The CDMRP uses a two-tier review process for proposals: scientific peer review, followed by programmatic review. Details of both tiers of review can be found in the Full Text of Program Announcement.
Estimated timelines for the FY05 Concept Awards are as follows: Full Proposal Submission Deadline: February 22, 2005, 5:00 p.m. Eastern Time; Peer Review: April, 2005; Programmatic Review: July, 2005; Award Start Date: Between September, 2005 and January, 2006.
For additional information or questions, please contact: Patricia A. Evans, Contracting/Grants Office, U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, phone: (301) 619-7354, Fax: (301) 619-6662, email: email@example.com
Who can apply:
Eligible functional categories:
Military Medical Research and Development
FY05 Neurofibromatosis Research Program (NFRP) Announcements
If you have problems accessing the full announcement, please contact:
US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014